Literature DB >> 19907415

Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic autoantibody-induced glomerulonephritis.

Adrian Schreiber1, Susanne Rolle, Ludmilla Peripelittchenko, Joerg Rademann, Wolfgang Schneider, Friedrich C Luft, Ralph Kettritz.   

Abstract

Antineutrophil cytoplasmic autoantibodies (ANCA) are associated with necrotizing crescentic glomerulonephritis (NCGN) and systemic vasculitis. We examined the role of phosphoinositol 3 kinase-gamma isoform (PI3Kgamma) in ANCA-activated neutrophil functions. Further, we tested whether its inhibition protects a mouse model of ANCA NCGN from developing NCGN. We transplanted bone marrow from wild-type mice or PI3Kgamma-deficient mice into myeloperoxidase-deficient mice immunized with myeloperoxidase. Bone marrow from PI3Kgamma(-/-) mice protected against development of the disease. Similarly, bone marrow transplanted from wild-type mice followed by treatment with the specific PI3Kgamma inhibitor AS605240 also protected these mice against NCGN in this model. AS605240 significantly abrogated myeloperoxidase- or proteinase 3-ANCA-stimulated superoxide production in vitro. Furthermore, ANCA-induced degranulation and GM-CSF-stimulated migration in a transwell assay of isolated human neutrophils were also abrogated by the drug. We found that PI3Kgamma plays a pivotal role in ANCA-induced NCGN and suggest that its specific inhibition may provide a novel treatment target.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19907415     DOI: 10.1038/ki.2009.420

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

Review 1.  How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.

Authors:  R Kettritz
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

Review 2.  Neutrophil migration: moving from zebrafish models to human autoimmunity.

Authors:  Miriam A Shelef; Sebastien Tauzin; Anna Huttenlocher
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

Review 3.  Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.

Authors:  C O S Savage
Journal:  Clin Exp Immunol       Date:  2011-05       Impact factor: 4.330

4.  Phosphoinositide 3-kinase γ deficiency attenuates kidney injury and fibrosis in angiotensin II-induced hypertension.

Authors:  Changlong An; Jia Wen; Zhaoyong Hu; William E Mitch; Yanlin Wang
Journal:  Nephrol Dial Transplant       Date:  2020-09-01       Impact factor: 5.992

5.  Myeloperoxidase-specific plasma cell depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-induced glomerulonephritis.

Authors:  Julia Bontscho; Adrian Schreiber; Rudolf A Manz; Wolfgang Schneider; Friedrich C Luft; Ralph Kettritz
Journal:  J Am Soc Nephrol       Date:  2011-01-13       Impact factor: 10.121

6.  Neutrophil extracellular traps can activate alternative complement pathways.

Authors:  H Wang; C Wang; M-H Zhao; M Chen
Journal:  Clin Exp Immunol       Date:  2015-06-22       Impact factor: 4.330

Review 7.  Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis.

Authors:  J Charles Jennette; Ronald J Falk; Adil H Gasim
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

Review 8.  Pathophysiology of ANCA-associated small vessel vasculitis.

Authors:  Cees G M Kallenberg
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

Review 9.  Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.

Authors:  J Charles Jennette; Ronald J Falk; Peiqi Hu; Hong Xiao
Journal:  Annu Rev Pathol       Date:  2013-01-24       Impact factor: 23.472

10.  Neutrophil Gelatinase-Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting TH17 Immunity.

Authors:  Adrian Schreiber; Anthony Rousselle; Jan Klocke; Sebastian Bachmann; Suncica Popovic; Julia Bontscho; Kai M Schmidt-Ott; Volker Siffrin; Uwe Jerke; Muhammad Imtiaz Ashraf; Ulf Panzer; Ralph Kettritz
Journal:  J Am Soc Nephrol       Date:  2020-06-02       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.